Effects of Diabetic Pharmacotherapy on Prolactin Hormone in Patients with Type 2 Diabetes Mellitus: Bane or Boon

Overview

Journal J Adv Pharm Technol Res

Date 2019 Nov 20

PMID 31742116

Citations 23

Authors

Huda Abdulbaki Rasheed

Hayder M Al-Kuraishy

Ali I Al-Gareeb

Nawar Raad Hussien

Marwa S Al-Nami

Affiliations

Soon will be listed here.

Abstract

Prolactin is a polypeptide hormone secreted from the anterior part of the pituitary gland which was implicated as a diabetogenic factor in the pathogenesis of type 2 diabetes mellitus (T2DM). Therefore, the aim of the present study was to evaluate prolactin serum levels in patients with T2DM regarding the effect of diabetic pharmacotherapy. Eighty patients with T2DM compared with 25 male healthy controls were recruited and divided into four groups: Group I - 29 patients with T2DM treated with metformin, Group II - 30 patients with T2DM treated with glyburide, Group III - 21 patients with T2DM treated with glyburide plus metformin, and Group IV - 25 control male healthy patients. Prolactin serum levels were high in patients with T2DM compared with controls ( < 0.01). Prolactin serum levels were higher in glyburide-treated patients compared with metformin-treated patients ( < 0.01). This study concludes that high prolactin levels in patients with T2DM are linked with diabetic complications and regarded as a beneficial phenomena to overcome IR and diabetic complications. Metformin but not glyburide reduced prolactin levels due to the improvement of insulin resistance.

Citing Articles

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery.

Alsaleem M, Al-Kuraishy H, Al-Gareeb A, Abdel-Fattah M, Alrouji M, Al-Harchan N J Cell Mol Med. 2025; 29(5):e70378.

PMID: 40040308 PMC: 11880132. DOI: 10.1111/jcmm.70378.

Autophagy modulators in type 2 diabetes: A new perspective.

Zaidalkilani A, Al-Kuraishy H, Fahad E, Al-Gareeb A, Elewa Y, Zahran M J Diabetes. 2024; 16(12):e70010.

PMID: 39676616 PMC: 11647182. DOI: 10.1111/1753-0407.70010.

Current Insights in Prolactin Signaling and Ovulatory Function.

Szukiewicz D Int J Mol Sci. 2024; 25(4).

PMID: 38396659 PMC: 10889014. DOI: 10.3390/ijms25041976.

Role of fenofibrate in multiple sclerosis.

Abulaban A, Al-Kuraishy H, Al-Gareeb A, Elekhnawy E, Alanazi A, Alexiou A Eur J Med Res. 2024; 29(1):113.

PMID: 38336772 PMC: 10854163. DOI: 10.1186/s40001-024-01700-2.

New insights on the potential effect of progesterone in Covid-19: Anti-inflammatory and immunosuppressive effects.

Al-Kuraishy H, Al-Maiahy T, Al-Gareeb A, Alexiou A, Papadakis M, Elhussieny O Immun Inflamm Dis. 2023; 11(11):e1100.

PMID: 38018575 PMC: 10683562. DOI: 10.1002/iid3.1100.

References

Sengupta S, Jaseem T, Ambalavanan J, Hegde A . Homeostatic Model Assessment-Insulin Resistance (HOMA-IR 2) in Mild Subclinical Hypothyroid Subjects. Indian J Clin Biochem. 2018; 33(2):214-217. PMC: 5891447. DOI: 10.1007/s12291-017-0647-4. View

Hwang Y, Morrow D, Cannon C, Liu Y, Bergenstal R, Heller S . High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial. Diabetes Obes Metab. 2017; 20(3):654-659. PMC: 5836896. DOI: 10.1111/dom.13136. View

Melnik B . Milk signalling in the pathogenesis of type 2 diabetes. Med Hypotheses. 2011; 76(4):553-9. DOI: 10.1016/j.mehy.2010.12.017. View

Yu J, Xiao F, Zhang Q, Liu B, Guo Y, Lv Z . PRLR regulates hepatic insulin sensitivity in mice via STAT5. Diabetes. 2013; 62(9):3103-13. PMC: 3749345. DOI: 10.2337/db13-0182. View

Al-Kuraishy H, Al-Gareeb A . Effect of orlistat alone or in combination with on visceral adiposity index in obese patients. J Intercult Ethnopharmacol. 2016; 5(4):408-414. PMC: 5061485. DOI: 10.5455/jice.20160815080732. View

Luo C, Wang X, Huang H, Mao X, Zhou H, Liu Z . Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis. Front Pharmacol. 2019; 10:371. PMC: 6465968. DOI: 10.3389/fphar.2019.00371. View

Al-Kuraishy H, Al-Gareeb A . Effects of rosuvastatin on metabolic profile: Versatility of dose-dependent effect. J Adv Pharm Technol Res. 2019; 10(1):33-38. PMC: 6383350. DOI: 10.4103/japtr.JAPTR_330_18. View

Al-Kuraishy H, Al-Gareeb A . Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile. J Basic Clin Pharm. 2017; 8(1):8-14. PMC: 5201066. DOI: 10.4103/0976-0105.195080. View

Brandebourg T, Hugo E, Ben-Jonathan N . Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab. 2007; 9(4):464-76. DOI: 10.1111/j.1463-1326.2006.00671.x. View

10.

Alkuraishy H, Al-Gareeb A . New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study. Emerg Med Int. 2015; 2015:283021. PMC: 4670866. DOI: 10.1155/2015/283021. View

11.

Shao S, Yao Z, Lu J, Song Y, He Z, Yu C . Ablation of prolactin receptor increases hepatic triglyceride accumulation. Biochem Biophys Res Commun. 2018; 498(3):693-699. DOI: 10.1016/j.bbrc.2018.03.048. View

12.

ter Braak E, Appelman A, van der Tweel I, Willem Erkelens D, van Haeften T . The sulfonylurea glyburide induces impairment of glucagon and growth hormone responses during mild insulin-induced hypoglycemia. Diabetes Care. 2002; 25(1):107-12. DOI: 10.2337/diacare.25.1.107. View

13.

Al-Kuraishy H, Al-Gareeb A, Al-Buhadilly A . Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome. Diseases. 2018; 6(1). PMC: 5871955. DOI: 10.3390/diseases6010009. View

14.

Lopez Vicchi F, Luque G, Brie B, Nogueira J, Tornadu I, Becu-Villalobos D . Dopaminergic drugs in type 2 diabetes and glucose homeostasis. Pharmacol Res. 2016; 109:74-80. DOI: 10.1016/j.phrs.2015.12.029. View

15.

Daimon M, Kamba A, Murakami H, Mizushiri S, Osonoi S, Yamaichi M . Association between serum prolactin levels and insulin resistance in non-diabetic men. PLoS One. 2017; 12(4):e0175204. PMC: 5383244. DOI: 10.1371/journal.pone.0175204. View

16.

Larsson A, Hagstrom E, Nilsson L, Svensson M . Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol. Ups J Med Sci. 2018; 123(2):94-99. PMC: 6055750. DOI: 10.1080/03009734.2018.1465496. View

17.

Al-Kuraishy H, Al-Gareeb A . Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins. J Lab Physicians. 2017; 9(3):163-169. PMC: 5496293. DOI: 10.4103/0974-2727.208263. View

18.

Al-Gareeb A, Abd Al-Amieer W, Alkuraishy H, J Al-Mayahi T . Effect of body weight on serum homocysteine level in patients with polycystic ovarian syndrome: A case control study. Int J Reprod Biomed. 2016; 14(2):81-8. PMC: 4869157. View

19.

Peric B, Kruljac I, Sundalic S, Pecina H, Jovic A, Stefanovic M . Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?. Endocr Res. 2016; 41(3):200-6. DOI: 10.3109/07435800.2015.1135444. View

20.

Witkowska Nery E, Kubota L . Evaluation of enzyme immobilization methods for paper-based devices--A glucose oxidase study. J Pharm Biomed Anal. 2015; 117:551-9. DOI: 10.1016/j.jpba.2015.08.041. View